Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults
- PMID: 2182673
- PMCID: PMC269668
- DOI: 10.1128/jcm.28.3.596-599.1990
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults
Erratum in
- J Clin Microbiol 1990 Jun;28(6):1491
Abstract
To investigate the immunogenicity and protective efficacy of cold-adapted influenza vaccine in individuals with underlying immunity to influenza A virus, we administered cold-adapted H1N1 and H3N2 vaccines to adults with prevaccination serum hemagglutination inhibition antibody titers of 1:16 or more and challenged them 1 month afterwards with homologous wild-type influenza A virus. Both cold-adapted vaccines were immunogenic in seropositive adults. In addition, individuals receiving cold-adapted vaccines had lower rates of virus shedding and illness following challenge with wild-type influenza virus than did unvaccinated seropositive volunteers.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical